A decade of declining prostatectomy margin positivity within a prostate cancer clinical quality registry

Papa, N; Perera, M; Bensley, JG; Evans, M; Millar, J; Frydenberg, M; Murphy, DG; Bolton, D

Author(s): Papa, N; Perera, M; Bensley, JG; Evans, M; Millar, J; Frydenberg, M; Murphy, DG; Bolton, D;
Details: Publication Year 2022-12,Volume 40,Issue #12,Page 537.e19-537.e24
Journal Title: Urologic Oncology
Publication Type: Research article
Abstract: CONTEXT: Positive surgical margin (PSM) on radical prostatectomy (RP) is associated with an increased risk of biochemical recurrence and use of salvage therapies. Given these adverse consequences, exploration of time trends and predictors of PSM will improve the patient outcomes following surgery for prostate cancer. METHODS: Pathological data from RP patients treated from 2011 to 2020 was extracted from the Victorian Prostate Cancer Outcomes Registry. This is a clinical quality registry that regularly benchmarks and reports back to individual clinicians the PSM percentage for their patients. Trends in PSM over time were visualized with separate running mean plots for both pT2 and pT3/4 disease. Predictors of PSM were explored with multivariable regression with date of surgery, surgical method, and hospital type, public or private, entered as covariates. RESULTS: In total, 12,394 patients formed the sample with PSM recorded in 25% (n = 3,141) of patients, 12% (777/6,640) in pT2 disease and 41% (2,364/5,754) in pT3/4 disease. Comparing 2011-12 to 2019-20, the pT3/4 PSM proportion declined from 50% to 38% while pT2 percentages were steady at 13%. In "high volume" institutions, pT2 PSM fell from 12% to 6.5%. Independent predictors of lower PSM were robotic vs. open method and being treated at a private vs. public institution. CONCLUSION: A clear decline in the proportion of pT3 PSM was observed in a large prostate cancer registry. Proposed explanatory factors include improved technical proficiency with robotic surgery and participation in a registry-based quality improvement initiative.
Keywords: Male; Humans; *Margins of Excision; Prostatectomy/methods; Prostate/pathology; *Prostatic Neoplasms/surgery/pathology; Registries; Neoplasm Recurrence, Local/pathology; Prostate cancer; Prostatectomy; Registry; Robotic surgery; Surgical margins
Department(s): Surgical Oncology
PubMed ID: 36167774
Publisher's Version: https://doi.org/10.1016/j.urolonc.2022.08.012
Terms of Use/Rights Notice: Refer to copyright notice on published article.

Creation Date: 2025-02-14 06:27:56

Last Modified: 2025-02-14 06:31:35